Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?
Monnier
L
L
Department of Metabolic Diseases, Lapeyronie Hôpital, Montpellier, France.
D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000628:therapy; D018149:Glucose Intolerance; D005905:Glyburide / Q000627:therapeutic use; D006442:Glycated Hemoglobin; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000517:prevention & control; D019518:Postprandial Period
D005905:Glyburide; D006442:Glycated Hemoglobin; D065089:Glycoside Hydrolase Inhibitors